Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarissa C Lee

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Reviews. Immunology|February 4, 2012
Accessory molecules for Toll-like receptors and their functionClarissa C Lee, Ana M Avalos, Hidde L Ploegh
The Journal of Biological Chemistry|May 1, 2014
The protein synthesis inhibitor blasticidin s enters mammalian cells via leucine-rich repeat-containing protein 8DClarissa C Lee, Elizaveta Freinkman, David M Sabatini, et al.
Plos One|July 18, 2013
A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κBClarissa C Lee, Jan E Carette, Thijn R Brummelkamp, et al.
Nature Immunology|October 22, 2008
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9Boyoun Park, Melanie M Brinkmann, Eric Spooner, et al.
The Plant Cell|May 8, 2012
required to maintain repression2 is a novel protein that facilitates locus-specific paramutation in maizeJoy-El R Barbour, Irene T Liao, Jennifer L Stonaker, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor ActivityJim Li, Lijing Chen, Roland J Billedeau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Reviews. Immunology|February 4, 2012
Accessory molecules for Toll-like receptors and their functionClarissa C Lee, Ana M Avalos, Hidde L Ploegh
The Journal of Biological Chemistry|May 1, 2014
The protein synthesis inhibitor blasticidin s enters mammalian cells via leucine-rich repeat-containing protein 8DClarissa C Lee, Elizaveta Freinkman, David M Sabatini, et al.
Plos One|July 18, 2013
A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κBClarissa C Lee, Jan E Carette, Thijn R Brummelkamp, et al.
Nature Immunology|October 22, 2008
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9Boyoun Park, Melanie M Brinkmann, Eric Spooner, et al.
The Plant Cell|May 8, 2012
required to maintain repression2 is a novel protein that facilitates locus-specific paramutation in maizeJoy-El R Barbour, Irene T Liao, Jennifer L Stonaker, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Journal of Medicinal Chemistry|December 19, 2022
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor ActivityJim Li, Lijing Chen, Roland J Billedeau, et al.
Pageof 1